Promethazine affects autonomic cardiovascular mechanisms minimally

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 839-844

  Brown, Troy E ^a,b   Eckberg, Dwain L ^a  

^a Neurology Service   (United States)

^b KRUG Life Sciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; NORADRENALIN; PROMETHAZINE;

ADULT; ANTICHOLINERGIC EFFECT; ANXIETY; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR EFFECT; CAROTID SINUS PRESSORECEPTOR REFLEX; CATECHOLAMINE BLOOD LEVEL; DROWSINESS; EXCITATION; FATIGUE; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MICROGRAVITY; NORMAL HUMAN; PRIORITY JOURNAL; RR INTERVAL; SPACE FLIGHT; TIDAL VOLUME; VERTIGO; XEROSTOMIA;

NASA DISCIPLINE CARDIOPULMONARY; NON-NASA CENTER;

ADULT; ANTIEMETICS; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; FEMALE; HUMANS; MALE; PROMETHAZINE; REFERENCE VALUES; SPACE MOTION SICKNESS;

EID: 0030746314     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. AKSELROD, S., GORDON, D., MADWED, J. B., SNIDMAN, N. C., SHANNON, D, C. AND COHEN, R. J.: Hemodynamic regulation: investigation by spectral analysis. Am. J. Physiol. 249 (Heart Circ. Physiol. 18): H867-H875, 1985.
2. AKSELROD, S., GORDON, D., UBEL, F. A., SHANNON, D. C., BARGER, A. C. AND COHEN, R. J.: Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science (Wash. D.C.) 213: 220-222, 1981.
3. ARONSON, C. E. AND HANNO, E. R. S.: Effects of promethazine on the isolated perfused rat heart. Gen. Pharmacol. 10: 389-395, 1979.
4. BAGIAN, J. P.: First intramuscular administration in the U. S. space program. J. Clin. Pharmacol. 31: 920, 1991.
5. BAGIAN, J. P. AND WARD, D. F.: A retrospective study of promethazine and its failure to produce the expected incidence of sedation during space flight. J. Clin. Pharmacol. 34: 649-651, 1994.
6. BROWN, T. E., BEIGHTOL. L. A., KOH, J. AND ECKBERG, D. L.: Important influence of respiration on human R-R interval power spectra is largely ignored. J. Appl. Physiol. 75: 2310-2317, 1993.
7. CLARKE, C. H. AND NICHOLSON, A. N.: Performance studies with antihistamines. Br. J. Clin. Pharmacol. 6: 31-35, 1978.
8. COVERT, R. F., DRUMMOND, W. H., WEBB, I. B. AND GIMOTTY, P. A.: Pulmonary and systemic vascular response to promethazine in conscious lambs. Pediatr. Cardiol. 9: 137-141, 1988.
9. DAVIS, J. R., JENNINGS, R. T., BECK, B. G. AND BAGIAN, J. P.: Treatment efficacy of intramuscular promethazine for space motion sickness. Aviat. Space Environ. Med. 64: 230-233, 1993.
10. DAVIS, J. R., VANDERPLOEG, J. M., SANTY, P. A., JENNINGS, R. T. AND STEWART, D. F.: Space motion sickness during 24 flights of the Space Shuttle. Aviat. Space Environ. Med. 59: 1185-1189, 1988.
11. DERENDORF, H.: Pharmacokinetic/pharmacodynamic consequenses of space flight. J. Clin. Pharmacol. 34: 684-691, 1994.
12. DODSON, M. E. AND EASTLEY, R. J.: Comparative study of two long-acting tranquillizers for oral premedication. Br. J. Anaesth. 50: 1059-1064, 1978.
13. ECKBERG, D. L., BROWN, T. E., BEIGHTOL, L. A. AND TAYLOR, J. A.: Influence of microgravity upon the carotid baroreceptor-cardiac reflex response. In German Spacelab-Mission D-2 Results, pp. 17-18, Wissenschaftliche Projecktführung D-2, Köln, Germany, 1994.
14. ECKBERG, D. L., CONVERTINO, V. A., FRITSCH, J. M. AND DOERR, D. F.: Reproducibility of human vagal carotid baroreceptor-cardiac reflex responses. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R215-R220, 1992.
15. EISENHOFER, G., GOLDSTEIN, D. S., STULL, R., KEISER, H. R., SUNDERLAND, T., MURPHY, D. L. AND KOPIN, I. J.: Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin. Chem. 32: 2030-2033, 1986.
16. FRITSCH, J. M. AND ECKBERG, D. L.: Effects of weightlessness on human baroreflex function (Abstract). Aviat. Space Environ. Med. 63: 439, 1992.
17. GOLDBERG, S. J., LINDE, L. M., WOLFE, R. R., GRISWOLD, W. AND MOMMA, K.: The effects of meperidine, promethazine, and chlorpromazine on pulmonary and systemic circulation. Am. Heart J. 77: 214-221, 1969.
18. GRAYBIEL, A. AND LACKNER, J. R.: Treatment of severe motion sickness with antimotion sickness drug injections. Aviat. Space Environ. Med. 58: 773-776, 1987.
19. HAYANO, J., SAKAKIBARA, Y., YAMADA, M., KAMIYA, T., FUJINAMI, T., YOKOYAMA, K., WATANABE, Y. AND TAKATA, K.: Diurnal variations in vagal and sympathetic cardiac control. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H642-H646, 1990.
20. HONZÍKOVÁ, N., PEŇÁZ, J. AND F̌ISER, B.: Individual features of circulatory power spectra in man. Eur. J. Appl. Physiol. 59: 430-434, 1990.
21. HYMAN, F. C., COLLINS, W. E., TAYLOR, H. L., DOMINO, E. F. AND NAGEL, R. J.: Instrument flight performance under the influence of certain combinations of antiemetic drugs. Aviat. Space Environ. Med. 59: 533-539, 1988.
22. JOHNSON, G. A., PEULER, J. D. AND BAKER, C. A.: Plasma catecholamines in normotensive subjects. Curr. Ther. Res. 21: 898-908, 1977.
23. KASTING, G. A., ECKBERG, D. L., FRITSCH, J. M. AND BIRKETT, C. L.: Continuous resetting of the human carotid baroreceptor-cardiac reflex. Am. J. Physiol. 252 (Regulatory Integrative Comp. Physiol. 21): R732-R736, 1987.
24. KATONA, P. G. AND JIH, F.: Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. J. Appl. Physiol. 39: 801-805, 1975.
25. KITNEY, R. I.: Beat-by-beat interrelationships between heart rate, blood pressure, and respiration. In The Beat-by-beat Investigation of Cardiovascular Function, ed. by R. I. Kitney and O. Rompelman, pp. 146-178, Clarendon Press, Oxford, 1987.
26. KITNEY, R. I. AND ROMPELMAN, O.: Thermal entrainment patterns in heart rate variability. J. Physiol. (Lond.) 270: 41P-42P, 1977.
27. KOEPCHEN, H. P.: History of studies and concepts of blood pressure waves. In Mechanisms of Blood Pressure Waves, ed. by K. Miyakawa, H. P. Koepchen and C. Polosa, pp. 3-23, Japan Scientific Societies Press, Tokyo, Springer-Verlag, 1984.
28. KOH, J., BROWN, T. E., BEIGHTOL, L. A., HA, C. Y. AND ECKBERG, D. L.: Human autonomic rhythms: vagal cardiac mechanisms in tetraplegic subjects. J. Physiol. (Lond.) 474: 483-495, 1994.
29. KOTZAN, J. A., HONIGBERG, I. L., FRANCISCO, G. E., ZAMAN, R., STEWART, J. T. AND BROWN, W. J.: Rotary pursuit, a measure of human performance, and plasma concentrations of promethazine. Biopharm. Drug Dispos. 7: 293-300, 1986.
30. LACKNER, J. R. AND GRAYBIEL, A.: Use of promethazine to hasten adaptation to provocative motion. J. Clin. Pharmacol. 34: 644-648, 1994.
31. LILLIEFORS, H. W.: On the Kolmogorov-Smirnov test for normality with mean and variance unknown. J. Am. Stat. Assoc. 62: 399-402, 1967.
32. O'BRIEN, J. F., FALK, J. L., CAREY, B. E. AND MALONE, L. C.: Rectal thiopental compared with intramuscular meperidine, promethazine, and chlorpromazine for pediatric sedation. Ann. Emerg. Med. 20: 644-647, 1991.
33. O'NEILL, P. A., MORTON, P. B. AND STARK, R. D.: Chlorpromazine-a specific effect on breathlessness? Br. J. Clin. Pharmacol. 19: 793-797, 1985.
34. Ori, Z., Monir, G., Weiss, J., Sayhouni, X. AND Singer, D. H.: Heart rate variability. Frequency domain analysis. Cardiol. Clin. 10: 499-537, 1992.
35. PAGANI, M., LOMBARDI, F., GUZZETTI, S., RIMOLDI, O., FURLAN, R., PIZZINELLI, P., SANDRONE, G., MALFATTO, G., DELL'ORTO, S., PICCALUGA, E., TURIEL, M., BASELLI, G., CERUTTI, S. AND MALLIANI, A.: Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Cire. Res. 59: 178-193, 1986.
36. PEROUTKA, S. J. AND SNYDER, S. H.: Antiemetics: neurotransmitter receptor binding predicts therapeutic actions. Lancet 1: 658-659, 1982.
37. POMERANZ, B., MACAULAY, R. J. B., CAUDILL, M. A., KUTZ, I., ADAM, D., GORDON, D., KILBORN, K. M., BARGER, A. C., SHANNON, D. C., COHEN, R. J. AND BENSON, H.: Assessment of autonomic function in humans by heart rate spectral analysis. Am. J. Physiol. 248 (Heart Circ. Physiol. 17): H151-H153, 1985.
38. RABINER, L. R., SCHAFER, R. W. AND DLUGOS, D.: Periodogram method for power spectrum estimation. In Programs for Digital Signal Processing, ed. by Digital Signal Processing Committee, IEEE Acoustics, Speech, and Signal Processing Society, pp. 2.1-1-2.1-10, IEEE Press, New York, 1979.
39. 2 receptor antagonists and hepatic oxygen supply-demand relationship in pigs. Can. J. Anaesth. 38: 121-128, 1991.
40. RYCHLIK, G., RYCHLIK, E. AND WASIK, M.: Influence of promethazine on immune reactions. I. Characterization of promethazine effects on natural killer cell-mediated cytotoxicity. Immunopharmacology 15: 117-122, 1988.
41. SCHROEDER, D. J., COLLINS, W. E. AND ELAM, G. W.: Effects of some motion sickness suppressants on static and dynamic tracking performance. Aviat. Space Environ. Med. 56: 344-350, 1985.
42. SCHWINGHAMMER, T. L., JUHL, R. P., DITTERT, L. W., MELETHIL, S. K., KROBOTH, F. J. AND CHUNGI, V. S.: Comparison of the bioavailability of oral, rectal and intramuscular promethazine. Biopharm. Drug Dispos. 5: 185-194, 1984.
43. SLEIGHT, P., LA ROVERE, M. T., MORTARA, A., PINNA, G., MAESTRI, R., LEUZZI, S., BIANCHINI, B., TAVAZZI, L. AND BERNARDI, L.: Physiology and pathophysiology of heart rate and blood pressure variability in humans: Is power spectral analysis largely an index of baroreflex gain? Clin. Sci. (Lond.) 88: 103-109, 1995.
44. SNEDECOR, G. W. AND COCHRAN, W. G.: Statistical Methods. Iowa State University Press, Ames, IA, 1989.
45. SPRENKLE, J. M., ECKBERG, D. L., GOBLE, R. L., SCHELHORN, J. J. AND HALLIDAY, H. C.: Device for rapid quantification of human carotid baroreceptor-cardiac reflex responses. J. Appl. Physiol. 60: 727-732, 1986.
46. SUNAHARA, F. A., FAREWELL, J., MINTZ, L. AND JOHNSON, W. H.: Pharmacological interventions for motion sickness: cardiovascular effects. Aviat. Space Environ. Med. 58(Suppl. 9): A270-A276, 1987.
47. TIETZE, K. J. AND PUTCHA, L.: Factors affecting drug bioavailability in space. J. Clin. Pharmacol. 34: 671-676, 1994.
48. WELCH, P. D.: The use of fast Fourier transform for the estimation of power spectra: a method based on time averaging over short, modified periodograms. IEEE Trans. Audio Electroaccoust. AU-15: 70-73, 1967.
49. WOOD, C. D. AND GRAYBIEL, A.: Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. Aerospace Med. 39: 1341-1344, 1968.
50. WOOD, C. D., MANNO, J. E., MANNO, B. R., REDETZKI, H. M., WOOD, M. J. AND MIMS, M. E.: Evaluation of antimotion sickness drug side effects on performance. Aviat. Space Environ. Med. 56: 310-316, 1985.
51. WOOD, C. D., MANNO, J. E., WOOD, M. J., MANNO, B. R. AND REDETZKI, H. M.: Mechanisms of antimotion sickness drugs. Aviat. Space Environ. Med. 58(Suppl. 9): A262-A265, 1987.
52. WOOD, C. D., STEWART, J. J., WOOD, M. J. AND MIMS, M.: Effectiveness and duration of intramuscular antimotion sickness medications. J. Clin. Pharmacol. 32: 1008-1012, 1992.
53. ZIMMER, E. Z., VADASZ, A. AND REEM, Z.: Intrapartum fetal vibratory acousstic stimulation during spontaneous and induced states of low activity and low heart rate variability. J. Reprod. Med. 35: 250-255, 1990.